CClinicalTrials.gg
CompletedNCT02557373Updated Jul 21, 2017

Pilot Feasibility of Rice Bran Supplementation in Children

An interventional study of Vitamin A and Rice Bran + Vitamin A in Dietary Rice Bran Supplementation, sponsored by Colorado State University. Completed at 2 sites in 2 countries. Open to participants aged 4 Months to 10 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-07-21.

Sponsored by Colorado State University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
4 Months to 10 Months
Sex
All
01

Study summary

The purpose of this study is to assess feasibility of rice bran consumption in weaning children and to identify dietary rice bran mediated changes to the stool microbiome and stool metabolome.

Read the detailed description

Rice bran is a globally accessible, underutilized food ingredient with an array of beneficial nutrients (e.g. phytochemicals and prebiotics) that promote health and potentially prevent diseases. The investigators will determine if dietary rice bran intake can modulate the infant gut microbiome and metabolome to promote gut immunity for the benefit of preventing diarrheal diseases that increase risk for malnutrition and stunting.

The investigators hope to learn about the feasibility of dietary supplementation of heat-stabilized rice bran in weaning children living in regions with increased susceptibility to diarrhea and malnutrition, and whether or not rice bran consumption can modulate the stool microbiome and metabolome.

02

Conditions studied

  • Dietary Rice Bran Supplementation

Keywords

  • rice bran
  • infants
  • stool metabolome and microbiome
  • dietary intervention
03

In context

Lead sponsor

Colorado State University is the lead sponsor of 112 studies on the registry; 19 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Months to 10 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Children between the ages of 4-6 months at beginning of recruitment
  • Families willing to feed their infant a daily dose of study-provided heat-stabilized rice bran supplementation for 3 months
  • Hemoglobin level >7 g/dl
  • Absence of intestinal parasites or malaria infection
  • Have not yet received Vitamin A supplementation

Exclusion criteria

Exclusion Criteria:

  • Have had a diarrheal episode between 5 and 6 months of age
  • Have had a prior hospitalization
  • Have had an antibiotic or prophylactic treatment within 1 month prior to participation
  • Have an ongoing illness, a known immunocompromising condition, or use of medications
  • Hemoglobin level \<7 g/dl
  • Presence of intestinal parasites or malaria infection
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
48 participants (actual)

Study arms

  • Placebo comparator
    Vitamin A

    Randomized participants will receive a one-dose of vitamin A supplementation (100,000 IU) at the beginning of the trial.

    Dietary Supplement: Vitamin A

  • Experimental
    Rice Bran + Vitamin A

    Randomized participants will receive a one-dose of vitamin A supplementation (100,000 IU) at the beginning of the trial plus consume a measured dose of rice bran daily.

    Dietary Supplement: Rice Bran + Vitamin A

Interventions

  • Dietary supplementVitamin A

    100,000 IU (oral supplement) on Day 1 of the intervention. No additional Vitamin A supplementation.

  • Dietary supplementRice Bran + Vitamin A

    100,000 IU (oral supplement) on Day 1 of the intervention. No additional Vitamin A supplementation. Dietary rice bran consumed daily and amounts increase throughout the 3 month intervention (6 months of age: 1 g/day rice bran, 7 months: 2 g/day rice bran, 8 months: 3 g/day)

    Also known as: whole food dietary intervention

06

What researchers measure

Primary outcomes

  1. Number of participants who are compliant to consuming rice bran daily and in amounts provided.

    Record daily rice bran consumption and track compliance to diet intervention by regular visits from local community health workers.

    Time frame: 3 months

Secondary outcomes

  1. Number of participants with microbial modulations in stool as detected by microbiome sequencing

    Measure the stool microbiome modulation with rice bran consumption for gut health and diarrhea prevention compared to a Vitamin A supplementation alone.

    Time frame: 3 months

  2. Number of participants with metabolite modulations in stool as detected by Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography-Mass Spectrometry (LC-MS)

    Measure the stool metabolome modulation with rice bran consumption for gut health and diarrheal prevention compared to a Vitamin A supplementation alone.

    Time frame: 3 months

07

Study locations

2 sites
  • Colorado State University
    Fort Collins, Colorado 80523, United States
  • University of Science, Techniques and Technologies of Bamako
    Bamako, Mali
08

References and documents

Publications

  • Goodyear A, Kumar A, Ehrhart EJ, Swanson KS, Grusak MA, Leach JE, Dow SW, McClung A, Ryan EP. Dietary rice bran supplementation differentially prevents Salmonella colonization across varieties and by priming intestinal immunity. J Funct Foods (2015 - in press).
  • Yang X, Wen K, Tin C, Li G, Wang H, Kocher J, Pelzer K, Ryan E, Yuan L. Dietary rice bran protects against rotavirus diarrhea and promotes Th1-type immune responses to human rotavirus vaccine in gnotobiotic pigs. Clin Vaccine Immunol. 2014 Oct;21(10):1396-403. doi: 10.1128/CVI.00210-14. Epub 2014 Jul 30. PubMed 25080551 ↗
  • Borresen EC, Ryan EP. Rice Bran: A food ingredient with Global Public Health Opportunities In: Watson RR, Preedy, V. R. and Zibadi, S.,editor. Wheat and Rice in Disease Prevention and Health: Benefits, risks, and mechanisms of whole grains in health promotion. 1st ed. Oxford, UK: Elsevier; 2014 p. 301-11.
  • Kumar A, Henderson A, Forster GM, Goodyear AW, Weir TL, Leach JE, Dow SW, Ryan EP. Dietary rice bran promotes resistance to Salmonella enterica serovar Typhimurium colonization in mice. BMC Microbiol. 2012 Jul 4;12:71. doi: 10.1186/1471-2180-12-71. PubMed 22583915 ↗
  • Henderson AJ, Kumar A, Barnett B, Dow SW, Ryan EP. Consumption of rice bran increases mucosal immunoglobulin A concentrations and numbers of intestinal Lactobacillus spp. J Med Food. 2012 May;15(5):469-75. doi: 10.1089/jmf.2011.0213. Epub 2012 Jan 16. PubMed 22248178 ↗
  • Borresen EC, Stone C, Bore A, Cissoko A, Maiga A, Koita OA, Ryan EP. Assessing Community Readiness to Reduce Childhood Diarrheal Disease and Improve Food Security in Dioro, Mali. Int J Environ Res Public Health. 2016 Jun 8;13(6):571. doi: 10.3390/ijerph13060571. PubMed 27338428 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 21, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02557373
Lead sponsor
Colorado State University
Collaborators
University of the Sciences, Techniques and Technologies of Bamako
Responsible party
Elizabeth P Ryan (Assistant Professor, Colorado State University) — Principal investigator
First posted
Sep 23, 2015
Start date
Aug 2015
Primary completion
May 2016
Completion
May 2016
Last update
Jul 21, 2017

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion